These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26762338)

  • 21. Evaluation of an abbreviated impactor for fine particle fraction (FPF) determination of metered dose inhalers (MDI).
    Guo C; Ngo D; Ahadi S; Doub WH
    AAPS PharmSciTech; 2013 Sep; 14(3):1004-11. PubMed ID: 23780781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI).
    Rowland M; Cavecchi A; Thielmann F; Kulon J; Shur J; Price R
    Pharm Res; 2018 Nov; 36(1):15. PubMed ID: 30478630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
    Berlinski A; Pennington D
    Respir Care; 2017 Sep; 62(9):1123-1130. PubMed ID: 28611228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of nonideal cascade impactor stage collection efficiency curves on the interpretation of the size of inhaler-generated aerosols.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2013 Jun; 14(2):497-510. PubMed ID: 23508617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of dry powder inhaler (DPI) resistance and aerosol dispersion timing on emitted aerosol aerodynamic particle sizing by multistage cascade impactor when sampled volume is reduced from compendial value of 4 L.
    Mohammed H; Arp J; Chambers F; Copley M; Glaab V; Hammond M; Solomon D; Bradford K; Russell T; Sizer Y; Nichols SC; Roberts DL; Shelton C; Greguletz R; Mitchell JP
    AAPS PharmSciTech; 2014 Oct; 15(5):1126-37. PubMed ID: 24871551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of delivery characteristics from a combination metered-dose inhaler using the Andersen cascade impactor and the next generation pharmaceutical impactor.
    Guo C; Gillespie SR; Kauffman J; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3321-34. PubMed ID: 17932959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are valved holding chambers (VHCs) interchangeable? An in vitro evaluation of VHC equivalence.
    Dissanayake S; Nagel M; Falaschetti E; Suggett J
    Pulm Pharmacol Ther; 2018 Feb; 48():179-184. PubMed ID: 29024795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. InVitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator.
    Hira D; Okuda T; Mizutani A; Tomida N; Okamoto H
    J Pharm Sci; 2018 Jun; 107(6):1731-1735. PubMed ID: 29428382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particle Size Measurements from Orally Inhaled and Nasal Drug Products.
    Mitchell JP
    J Aerosol Med Pulm Drug Deliv; 2021 Dec; 34(6):325-345. PubMed ID: 34860563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.
    Kamiya A; Sakagami M; Byron PR
    J Pharm Sci; 2009 Mar; 98(3):1028-39. PubMed ID: 18661538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler.
    Abadelah M; Hazim F; Chrystyn H; Bagherisadeghi G; Rahmoune H; Larhrib H
    Eur J Pharm Sci; 2017 Jun; 104():180-187. PubMed ID: 28351669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal Inhalation Profile of Pressurized Metered Dry Powder Inhaler Using a Valved Holding Chamber: A Dynamic Analysis.
    Kondo T; Tanigaki T; Hibino M; Horiuchi S; Maeda K; Tobe S; Kamada R; Watanabe S
    J Aerosol Med Pulm Drug Deliv; 2024 Jun; 37(3):132-139. PubMed ID: 38648279
    [No Abstract]   [Full Text] [Related]  

  • 33. Application of heated inlet extensions to the TSI 3306/3321 system: comparison with the Andersen cascade impactor and next generation impactor.
    Myrdal PB; Mogalian E; Mitchell J; Nagel M; Wright C; Kiser B; Prell M; Woessner M; Stein SW
    J Aerosol Med; 2006; 19(4):543-54. PubMed ID: 17196082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next generation pharmaceutical impactor: a new impactor for pharmaceutical inhaler testing. Part III. extension of archival calibration to 15 L/min.
    Marple VA; Olson BA; Santhanakrishnan K; Roberts DL; Mitchell JP; Hudson-Curtis BL
    J Aerosol Med; 2004; 17(4):335-43. PubMed ID: 15699634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
    Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
    Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved laboratory test methods for orally inhaled products.
    Mitchell JP; Nagel MW
    Ther Deliv; 2013 Aug; 4(8):1003-26. PubMed ID: 23919476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro performance of three small-volume valved holding chambers with beclomethasone/formoterol pressurized metered dose inhaler.
    Goncalves TM; Alhanout K; Nicolay A; Dubus JC; de Santana DP; Andrieu V
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):223-7. PubMed ID: 23094686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
    Chambers F; Ludzik A
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
    Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically relevant test methods to establish in vitro equivalence for spacers and valved holding chambers used with pressurized metered dose inhalers (pMDIs).
    Mitchell J; Dolovich MB
    J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):217-42. PubMed ID: 22857273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.